Form 4 for RYTM RHYTHM PHARMACEUTICALS, INC.
Accepted 2025-07-08 00:00:00 ET · period of report 2025-07-07 · accession 0001104659-25-066420 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-07-08 | 2025-07-07 | RYTM | Smith Hunter C | CFO | M - OptEx | $6.88 | +6,986 | 116.9K | +6% | +$48.1K |
| D | 2025-07-08 | 2025-07-07 | RYTM | Smith Hunter C | CFO | M - OptEx | $0.00 | -6,986 | 70.2K | -9% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-07-07 | M | A | 6,986 | $6.88 | 116,915 | D | — | — | |
| 2 | Derivative | Stock Options (Right to Buy) | 2025-07-07 | M | D | 6,986 | $0.00 | 70,208 | D | $6.88 · — to 2027-08-08 | 6,986 Common Stock | (F1) The stock option is fully vested. |